Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years

Size: px
Start display at page:

Download "Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years"

Transcription

1 DOI: /j x Gynaecological oncology Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years R Manchanda, P Baldwin, R Crawford, SL Vowler, R Moseley, J Latimer, K Welton, M Shafi Department of Gynaecology, Division of Gynaecological Oncology, Addenbrooke s Hospital, Cambridge, UK Correspondence: Dr R Manchanda, Department of Gynaecological Oncology, EGA Institute for Women s Health, University College London, First Floor, Maple House, 149 Tottenham Court Road, London W1T 7NF, UK. r.manchanda@ucl.ac.uk Accepted 11 June Objective To establish the effect of margin status on recurrence following large loop excision of the transformation zone (LLETZ) in women over 50 years. Study design Prospectively collected data of women over 50 years, who underwent LLETZ for suspected cervical intraepithelial neoplasia between 1998 and 2003, were analysed. Women were followed up for up to over 6 years. Setting District colposcopy service based at a gynae-oncology cancer centre. Main outcome measures The main outcome measure included histologically detected recurrence. Any abnormal cytology on follow up was also documented. Methods Prospectively collected data were analysed from the colposcopy database. Recurrence was analysed using Kaplan Meir plots and Cox regression. Fisher s exact test was used to determine the association between margins and grade. The Kruskal Wallis and Mann Whitney U tests were used to compare age and duration of follow up between groups. Results A total of 118 women underwent LLETZ and 92 were included in the final analysis. Margins were designated as clear (n = 62), involved (n = 22) or uncertain (n = 8). Histological recurrence occurred in 12 while abnormal cytology was demonstrated in 17 women. One woman with involved margins developed cervical cancer. Individuals with clear margins were less likely to have recurrence than those with involved margins (Hazard Ratio (HR) 0.18, 95% CI: ). Involved margins were more common with high-grade than low-grade lesions (P = 0.002). Conclusion The data show an association between disease recurrence and the finding of involved margins in this cohort. Keywords CIN, LLETZ, margin status, over 50 years, recurrence. Please cite this paper as: Manchanda R, Baldwin P, Crawford R, Vowler SL, Moseley R, Latimer J, Welton K, Shafi M. Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years. BJOG 2008;115: Introduction Large loop excision of the transformation zone (LLETZ), also known as loop electrosurgical excision procedure in North America, is currently the most widely used method for treating cervical intraepithelial neoplasia (CIN) in the UK. This has been shown to reduce the risk of invasive cervical cancer by up to 95%. 1 Only a few studies have documented the pattern of long-term recurrence following LLETZ. 2 4 Limited data suggest that age more than 50 years 3,5 and the presence of disease at resected margins 5 7 are independent risk factors for recurrence. Revised British National guidelines (2004) recommend that women over the age of 50 years, with high-grade disease at the resected margin should have a repeat LLETZ to try to obtain clear margins. 8 Women with both these risk factors may be at particular risk of developing recurrent CIN and could benefit from active intervention in the form of repeat treatment rather than merely undergoing early follow up. Evidence is, however, lacking in this regard. This study aims to establish the effect of margin status on the risk of recurrence following LLETZ in women over the age of 50 years. Methods An analysis of prospectively collected data was performed using the colposcopy database at Addenbrooke s Gynaecological Oncology Centre, Cambridge, UK. The centre provides a district colposcopy service. The data of all women over the age of 50, who underwent LLETZ for suspected CIN between 1238 ª 2008 The Authors Journal compilation ª RCOG 2008 BJOG An International Journal of Obstetrics and Gynaecology

2 Recurrence after LLETZ for CIN in women over and 2003, were examined. All women were treated by accredited colposcopists at the cancer centre. LLETZ was performed routinely using a standard technique that has already been described elsewhere. 9 A see and treat policy was typically used for high-grade cytology and defer and treat for low-grade cytology. Following histological assessment, specimens were classified into high-grade lesions (HGL; CIN2, CIN3) and low-grade lesions (LGL; less than CIN2). Women were followed up, up to a period of over 6 years (median 4.3, range: years) in a manner consistent with existing national guidelines. Colposcopy and smear were performed at first follow up at 6 months in the treatment centre. Thereafter, follow-up smears were performed in primary care at 12 months post-treatment and subsequently at yearly intervals. Those women with abnormal smears were referred back for colposcopic assessment (at the treatment centre) with biopsy as necessary. Statistical analysis was carried out in SPSS V13.0 (SPSS Inc., Chicago, IL, USA), using Kaplan Meier plots and Cox regression. The Fisher s exact test was used to look at the association between margins and grade. Age and duration of follow up were not sufficiently normally distributed, and hence were compared between the different margin groups using nonparametric Kruskal Wallis test. As age showed a significant difference, post hoc pairwise tests were carried out using the Mann Whitney U test. The confidence interval on the difference of two proportions (converted to percentages) was used to compare margin status and grade between the different groups, in Stat-Xact V4.0 (Cytel Corp., Cambridge, MA, USA). Results From the database, 118 women over the age of 50 years who underwent LLETZ between 1998 and 2003 were identified. Of these, 92 were included in the final analysis. For the purpose of analysis, histology has been considered as the gold standard for diagnosis. Hence, those nine women who initially had inadequate (n = 3) or abnormal smears (three with borderline nuclear abnormalities and two with mild dyskaryosis and one with severe dyskaryosis) but no histologically proven CIN on either cervical biopsy or loop excision were excluded from the analysis. Other reasons for exclusion included the finding of cervical cancer (n = 6) and endometrial cancer (n = 1). There was absence of any follow-up data in seven women. Following histopathology review, three women underwent a repeat LLETZ within 6 8 weeks of the first procedure and were excluded from the analysis. Histological margins were found to be clear (complete excision) in 62 and involved (incomplete excision) in 22 histological specimens. In eight women, fragmentation or the poor orientation of the histological specimen prevented accurate assessment of the margin status. This group were deemed to have uncertain margins (Table 1). Table 1. Margin status, grade and recurrence Margins High grade, Low grade, Total Histological recurrence, Cytological recurrence, Involved 16 (72.7) 6 (27.3) 22 7 (31.8) 7 (31.8) Uncertain 4 (50.0) 4 (50.0) 8 0 (0.0) 1 (12.5) Clear 19 (30.6) 43 (69.4) 62 5 (8.1) 9 (14.5) Total 39 (42.4) 53 (57.6) Kaplan Meier plots were used to analyse recurrence. Overall mean time to recurrence was 73.2 months (95% CI: ) (Figure 1). When assessed by margin status, mean time to recurrence was 47.4 months (95% CI: ) in those with involved margins and 76.8 months (95% CI: ) in those with clear margins (Figure 2). Cox regression analysis demonstrates the significant effect of margin status on recurrence course (Table 2). Women with clear margins were less likely to have a recurrence than either those with involved margins (HR 0.18; 95% CI: ; P = 0.004) or the study group as a whole (P = 0.02). If the specimens were classified by histology into HGL (CIN2, CIN3) and LGL, a mean time to recurrence of 70.7 months (95% CI: ) was found in the HGL group and 71.6 months (95% CI: ) in the LGL group. It was not possible to compare the survival courses of these two groups as the proportional hazards assumption is not met. The relationship between margin status, grade of lesion and recurrence is given in Table 1. HGL are more likely to be associated with involved margins and LGL with clear margins Figure 1. Kaplan Meier plot for recurrence for whole cohort. Mean time to recurrence is 73.2 months (95% CI: ) in the whole cohort. ª 2008 The Authors Journal compilation ª RCOG 2008 BJOG An International Journal of Obstetrics and Gynaecology 1239

3 Manchanda et al. Figure 2. Kaplan Meier plot for recurrence according to margin status. Margins involved mean time to recurrence 47.4 months (95% CI: ). Clear margins mean time to recurrence 76.8 months (95% CI: ). (Fisher s exact test, FE(x) = 11.9; P = 0.002; Table 1). The percentage of HGL in the involved margin group was higher than the clear margin group by 42.1% (95% CI: %; P = 0.003). However, there was no evidence of an increase (22.7%, 95% CI: 18.0 to 61.7%) in HGL in the involved margins group compared with the uncertain margins group (P = 0.28). Those with involved margins can be further subclassified into the type of margin affected, that is, ectocervical, endocervical and deep stromal or lateral cervical (Table 3). However, the number of recurrences was insufficient to allow further investigation of these variables. Histologically proven recurrence occurred in 12 women and abnormal smears or cytological recurrence was found in 17 women (Table 1). One woman with involved margins developed cervical cancer. Her initial histology at LLETZ showed CIN2. Her follow up was uneventful until 56 months when she was found to have severe dyskaryosis. Subsequent cervical biopsy at colposcopy revealed CIN3. Moderately differentiated squamous cell carcinoma was diagnosed in Table 2. Results of Cox regression analysis Contrast df Significance HR (95% CI) Overall Uncertain margins versus margins involved Clear margins versus margins involved ( ) Cox regression analysis shows that there is a significant effect of margin involvement on the survival course. The hazard of recurrence was 0.18 (95% CI: ) in those with clear margins compared with those with margins involved (P ). the apical segment of the LLETZ specimen. Two women with involved margins who were detected to have histological recurrence also had a concurrent negative smear. Five women with involved margins and four with clear margins who had cytological recurrence at follow up showed no evidence of concurrent histological recurrence. The age distribution of those with involved, clear and uncertain margins ranged from 52 to 74 years, years and years, respectively. There was no evidence of a difference in the age distribution between the two main groups (involved and clear margins) using a Mann Whitney U test (U = 659, P = 0.82). However, overall, there was a significant difference in distribution of age between the three groups (Kruskal Wallis test, x 2 = 6.81, df =2,P = 0.033). This was due to the significant difference in age between clear margins and uncertain margins (U = 105.5, P = 0.006), and also between uncertain margins and involved margins (U = 44, P = 0.037). Using the Kruskal Wallis test, there was no evidence of a difference in follow up between the three groups (x 2 kw = 3.70, df =2,P = 0.16). Discussion Age over 50 years 5 or even 40 years 3 together with presence of disease at the resected margin 3,5 7 have been documented as independent risk factors for recurrence following LLETZ. Individuals with both these factors would constitute a group at significantly higher risk for recurrence. Our study clearly demonstrates the association between disease recurrence and margin status in women over 50 years by comparing those with involved and clear margins. To the best of our knowledge, this is the first study that looks at recurrence in this fashion, specifically in this composite high-risk group. Previous studies have looked at risks for recurrence (involved margins) in all ages 5 7 or compared outcomes in different age groups. 3,5 Although conservative treatment for CIN reduces the risk of cervical cancer by 95%, the risk is still around five times greater than the general population. 1 The majority of recurrences (80 87%) are reported to occur in the first months after LLETZ. 4,5 It has been suggested that earlier recurrence is more common with HGL. 4 It was not possible to perform a Cox regression analysis comparing recurrence course in HGL and LGL with our data as the proportional hazards assumption is not met. Six of the 12 recurrences occurred after 2 years in our study, with two of these occurring after 4.5 years. The recurrences were equally associated with HGL and LGL (six each). Two of these six HGL and four of the six LGL recurred after 2 years. Such late recurrences could reflect viral latency, re-infection or the natural history of persistent residual disease. Typically, recurrences within 2 years have been classified as persistent disease and those beyond this termed as true recurrences. 2,4,10 This classification 1240 ª 2008 The Authors Journal compilation ª RCOG 2008 BJOG An International Journal of Obstetrics and Gynaecology

4 Recurrence after LLETZ for CIN in women over 50 Table 3. Type of margin involved, grade and recurrence Involved margin n HGL, LGL, Histological recurrence, Cytological recurrence, Ectocervical only 8 5 (62.5) 3 (37.5) 3 (37.5) 3 (37.5) Endocervical only 11 9 (81.8) 2 (18.2) 4 (36.4) 3 (27.3) Lateral cervical 2 2 (100) (50) or deep stromal Endocervical and deep stromal (100) 0 0 is somewhat arbitrary and we prefer not to distinguish between the two, as it is not possible to be sure which represents true recurrence or residual disease. Hence, we have categorised all as recurrent CIN. The finding of late recurrence in this study is in agreement with previous publications 1,4 and emphasises the need for long-term follow up following LLETZ for CIN. Current British guidelines recommend that women should have annual follow up for at least 10 years after the treatment of CIN2 or worse before returning to the routine screening interval, whereas women treated for CIN1 may be returned to routine recall after 2 years of negative post-treatment cytology. Of the four late recurrences associated with LGL, three were from the clear margin group and one from the involved margin group. Our findings suggest that even women with LGL in this age group need to be followed up for a longer duration than the currently recommended 2 years. Although pathological evidence of incomplete excision of margins does not imply residual disease, 11 the risk of recurrence is clearly increased in these women. Almost one-third of women with involved margins had histologically proven recurrence in our series. Those with clear margins were less likely to develop recurrent CIN (HR 0.18 [95% CI: ]; P = 0.004; Figure 2, Table 2). The overall rate of recurrence was higher than has been previous documented. 11 This may be explained by the fact that our study group consists exclusively of women over 50 years age and hence, is inherently at a higher risk. Lesion size or the number of involved sectors of atypical transformation have been described as risk factors for recurrent CIN after treatment. 7 These data were not specifically recorded on our database and hence, could not be assessed. However, we did find that HGL were associated with a higher recurrence rate and it is these lesions which are likely to be larger in size 12,13 or more extensive. 14 HGL were more commonly associated with involved margins and LGL with clear margins (Table 1). Kruskal Wallis and Mann Whitney tests show no evidence of a difference in the age distribution and duration of follow up between the involved and clear margin groups. This further validates the inference of a clear association between risk of disease recurrence and margin status in these women. Among those with involved margins, the ectocervical margin was involved in 8, endocervical in 11, lateral cervical or deep stromal in 2 and both endocervical and deep stromal in 1 woman. It has been suggested that the risk of recurrence is mainly due to CIN at the endocervical margin. 5 However, in our series three recurrences were associated with ectocervical and four with endocervical involvement (Table 3). Unfortunately, the low number of recurrences prevents statistical analysis of the contribution of site of the involved margin towards the risk of recurrence. It has been proposed that cytology alone may be adequate to detect residual CIN at follow up. 11 However, if histological assessment is used as the gold standard for disease recurrence, the use of cervical cytology for post-treatment surveillance has a high false-positive rate (negative concurrent histology) of up to 43%. 15 Consistent with this, nine women with cytological abnormality at follow up showed no evidence of histological recurrence in our series. These nine women included five with involved margins. The use of colposcopy in the post-treatment setting could mitigate against such a potential for over diagnosis. However, post-treatment inflammatory changes may lead to the acetowhite of regenerating and undifferentiated epithelium being confused with that of CIN, and repeat LLETZ based on colposcopy alone is therefore associated with the finding of non-dysplastic histology in a greater proportion of women than at primary treatment. 2,3 Delaying initial follow up until 6 months may reduce the risk of confusing acetowhite of metaplastic epithelium with CIN. Colposcopic follow up has also been recommended following LLETZ where the excision has been ruled incomplete on the basis of histologically involved margins. 6,11 In the current series, two women with involved margins at primary treatment had histological recurrence detected at colposcopy following normal cervical smears. False-negative cytology may be common in this setting occurring in up to 47% of women. 3,11 Post-treatment colposcopic review offers the potential benefit of early diagnosis of treatment failures associated with false-negative smears. 3 The relatively poor sensitivity and specificity of cervical cytology must be balanced against the cost of routine colposcopy post-lletz and the risk of over treatment due to over interpretation of benign ª 2008 The Authors Journal compilation ª RCOG 2008 BJOG An International Journal of Obstetrics and Gynaecology 1241

5 Manchanda et al. cervical change. To date, it is our practise to perform a colposcopic examination and cervical cytology at first follow up in women over 50 years with involved margins. However, further prospective studies are needed to establish the benefit of colposcopy over cytology alone. Current UK national guidelines recommend repeat excision for the presence of CIN3 at the endocervical margin. 8 In this study, two of the seven (28%) recurrences in the involved margin group occurred in LGL in our series. Furthermore, three of the seven (42%) recurrences in this group were in women with ectocervical margin involvement only. The data suggest that it is worth considering performing a repeat LLETZ in all such women over the age of 50, irrespective of the type of margin involved. A second LLETZ may, however, increase the risk of cervical stenosis, thus making follow up more difficult. Ideally, an appropriately powered large randomised controlled trial would be needed to establish the efficacy of such a strategy. Conclusion There is a strong association between involved margins and recurrence of CIN in women over the age of 50 years. This finding suggests consideration should be given to repeat LLETZ in this high-risk group of women. It was not possible to establish the contribution of location of the involved margin to the recurrence risk and larger studies will be needed to resolve this issue. Disclosure of interest This article is original; does not infringe upon any copyright or other proprietary right of any third party; is not under consideration by another publication and has not been previously published. The authors confirm that the final manuscript has been read and that each author s contribution has been approved by the appropriate author. The authors declare no conflict of interest. Contribution to authorship R.M. was involved in data collection, analysis, drafting and writing of the paper. P.B., J.L., K.W., R.C. and M.S. contributed to writing of the manuscript and were responsible for the clinical care of the women. Robin Mosley reviewed the histological specimens and the final manuscript. S.L.V. performed the statistical analysis and has contributed to writing the statistical sections of the manuscript. The final draft was prepared by R.M., P.B., R.C., M.S. and approved by the others. Ethics approval The project was referred to the Chair of the Research Ethics committee (NHNNIN Joint REC reference number 07L 245). Under the Research Governance Framework, the project was deemed to be a clinical audit, and permission for data analysis and submission for publication was given. j References 1 Soutter WP, Lopes A, Fletcher A, Monaghan JM, Duncan ID, Paraskevaidis E, et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 1997;349: Bigrigg A, Haffenden DK, Sheehan AL, Codling BW, Read MD. Efficacy and safety of large-loop excision of the transformation zone. Lancet 1994;343: Flannelly G, Langhan H, Jandial L, Mann E, Campbell M, Kitchener H. A study of treatment failures following large loop excision of the transformation zone for the treatment of cervical intraepithelial neoplasia. Br J Obstet Gynaecol 1997;104: van Hamont D, van Ham MAPC, Struick-van der Zanden PHTH, Keijser KGG, Bulten J, Melchers WJG, et al. Long-term follow-up after large-loop excision of the transformation zone: evaluation of 22 years treatment of high-grade cervical intraepithelial neoplasia. Int J Gynecol Cancer 2006;16: Flannelly G, Bolger B, Fawzi H, Lopes A, Monaghan JM. Follow up after LLETZ: could schedules be modified according to risk of recurrence. BJOG 2001;108: Dobbs SP, Asmussen T, Nunns D, Hollingworth J, Brown LJR, Ireland D. Does histological incomplete excision of cervical intraepithelial neoplasia following large loop excision of transformation zone increase recurrence rates? A six year cytological follow up. BJOG 2000;107: Shafi MI, Dunn JA, Buxton EJ, Finn CB, Jordan JA, Luesley DM. Abnormal cervical cytology following large loop excision of the transformation zone: a case controlled study. Br J Obstet Gynaecol 1993;100: Colposcopy and Programme Management. Guidelines for the NHS Cervical Screening Programme. NHSCSP Publication No Sheffield, UK: NHS Cancer Screening Programmes. 9 Murdoch JB, Grimshaw RN, Monaghan JM. Loop diathermy excision of the abnormal cervical transformation zone. Int J Gynecol Cancer 1991; 1: Paraskevaidis E, Jandial L, Mann EM, Fisher PM, Kitchener HC. Pattern of treatment failure following laser for cervical intraepithelial neoplasia: implications for follow-up protocol. Obstet Gynecol 1991;78: Murdoch JB, Morgan PR, Lopes A, Monaghan JM. Histological incomplete excision of CIN after large loop excision of the transformation zone (LLETZ) merits careful follow up, not treatment. Br J Obstet Gynaecol 1992;99: Shafi MI, Finn CB, Luesley DM, Jordan JA, Dunn J. Lesion size and histology of atypical transformation zone. Br J Obstet Gynaecol 1991; 98: Jarmulowicz MR, Jenkins D, Barton SE Goodall AL, Hollongworth A, Singer A. Cytological status and lesion size: a further dimension in cervical intraepithelial neoplasia. Br J Obstet Gynaecol 1989;96: Anderson MC, Hartley RB. Cervical crypt involvement by intraepithelial neoplasia. Obstet Gynecol 1980;55: Buxton EJ, Luesley DM, Wade-Evans T, Jordan JA. Residual disease after cone biopsy: completeness of excision and follow-up cytology as predictive factors. Obstet Gynecol 1987;70: ª 2008 The Authors Journal compilation ª RCOG 2008 BJOG An International Journal of Obstetrics and Gynaecology

Completeness of excision and follow up cytology in patients treated with loop excision biopsy

Completeness of excision and follow up cytology in patients treated with loop excision biopsy J Clin Pathol ;:9 9 9 Department of Pathology, Mayday University Hospital, London Road, Thornton Heath, Surrey CR7 7YE, UK A M Zaitoun M J Coppen S M Thomas Department of Pathology, The Royal Surrey County

More information

A comparative study of two methods of large loop excision of the transformation zone

A comparative study of two methods of large loop excision of the transformation zone BJOG: an International Journal of Obstetrics and Gynaecology April 2005, Vol. 112, pp. 490 494 DOI: 10.1111/j.1471-0528.2005.00427.x A comparative study of two methods of large loop excision of the transformation

More information

Cryotherapy has No Place in Colposcopy Practice

Cryotherapy has No Place in Colposcopy Practice Cryotherapy has No Place in Colposcopy Practice No financial disclosures No conflicts of interest ? Precision? Personalized Medicine? Best Evidence Based Practice Prinicipals of Surgical Management CIN1

More information

The routine use of ZedScan within one colposcopy service in England. MC Macdonald, R Lyon, JE Palmer, JA Tidy

The routine use of ZedScan within one colposcopy service in England. MC Macdonald, R Lyon, JE Palmer, JA Tidy The routine use of ZedScan within one colposcopy service in England MC Macdonald, R Lyon, JE Palmer, JA Tidy Introduction Colposcopic impression alone has been shown to be subjective with variable rates

More information

Molecular markers for diagnosis and prognosis in cervical neoplasia Eijsink, Jasper Johannes Hendrikus

Molecular markers for diagnosis and prognosis in cervical neoplasia Eijsink, Jasper Johannes Hendrikus University of Groningen Molecular markers for diagnosis and prognosis in cervical neoplasia Eijsink, Jasper Johannes Hendrikus IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's

More information

What is being excised and why? Professor Henry Kitchener Institute of Cancer Sciences The University of Manchester

What is being excised and why? Professor Henry Kitchener Institute of Cancer Sciences The University of Manchester What is being excised and why? Professor Henry Kitchener Institute of Cancer Sciences The University of Manchester Qu. What is being excised? A. Colposcopic lesions which should contain CIN2+ Qu. Why is

More information

Efficacy of cervical intrarepithelial neoplasia (CIN)

Efficacy of cervical intrarepithelial neoplasia (CIN) The Ulster Medical Journal, Volume 72, No. 1, pp. 10-15, May 2003. Efficacy of cervical intrarepithelial neoplasia (CIN) treatment by cold coagulation A Zawislak, J H Price, H R McClelland, R G N Storey,

More information

Treatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman?

Treatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman? Treatment of Cervical Intraepithelial Neoplasia Karen Smith-McCune Professor, Department of Obstetrics, Gynecology and Reproductive Sciences I have no conflicts of interest Case How would you manage this

More information

Investigation of 100 consecutive negative cone biopsies

Investigation of 100 consecutive negative cone biopsies British Journal of Obstetrics and Gynaecology January 1997, Vol. 104, pp. 100-104 Investigation of 100 consecutive negative cone biopsies *Pouran Golbang Research Fellow and Consultant (Gynaecology), **James

More information

Scottish Cervical Screening Programme. Colposcopy and Programme Management

Scottish Cervical Screening Programme. Colposcopy and Programme Management Scottish Cervical Screening Programme Colposcopy and Programme Management Addendum to NHSCSP Publication No 20 Second Edition Exceptions Applicable in NHS Scotland April 2013 (Final Version 2.8 to incorporate

More information

THE NEW ZEALAND MEDICAL JOURNAL

THE NEW ZEALAND MEDICAL JOURNAL THE NEW ZEALAND MEDICAL JOURNAL Vol 8 No ISSN 75 876 Findings and outcome of teenage women referred for colposcopy at Christchurch Women s Hospital, New Zealand Peter Sykes, Dianne Harker, David Peddie

More information

Gynaecological surgery. Introduction. MJ Camargo, a FB Russomano, a MA Trist~ao, a G Huf, b W Prendiville c

Gynaecological surgery. Introduction. MJ Camargo, a FB Russomano, a MA Trist~ao, a G Huf, b W Prendiville c DOI: 10.1111/1471-0528.13200 www.bjog.org Gynaecological surgery Large loop versus straight-wire excision of the transformation zone for treatment of cervical intraepithelial neoplasia: a randomised controlled

More information

LLETZ (Large Loop Excision of the Transformation Zone) Fragmentation: Impact on Margin Assessment and Cervical Biopsy-LLETZ Correlation

LLETZ (Large Loop Excision of the Transformation Zone) Fragmentation: Impact on Margin Assessment and Cervical Biopsy-LLETZ Correlation LLETZ (Large Loop Excision of the Transformation Zone) Fragmentation: Impact on Margin Assessment and Cervical Biopsy-LLETZ Correlation Bridget Melley BSc. (Hons.) in Medical Science Galway-Mayo Institute

More information

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim Is vaccination with quadrivalent HPV vaccine after Loop Electrosurgical Excision Procedure effective in preventing recurrence in patients with High-grade Cervical Intraepithelial Neoplasia (CIN2-3)? Chonnam

More information

Management of Abnormal Cervical Cytology and Histology

Management of Abnormal Cervical Cytology and Histology Management of Abnormal Cervical Cytology and Histology Assoc. Prof. Gökhan Tulunay Etlik Zübeyde Hanım Women s Diseases Teaching & Research Hospital Gynecologic Oncology Clinic Universally accepted guideline

More information

An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia

An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia DOI:10.1111/j.1365-2303.2009.00695.x An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia S. A. Thiryayi, J. Marshall and D. N. Rana Manchester

More information

A clinical review of borderline glandular cells reported on liquid-based cervical cytology

A clinical review of borderline glandular cells reported on liquid-based cervical cytology DOI: 10.1111/j.1471-0528.2009.02477.x www.bjog.org Gynaecological oncology A clinical review of borderline glandular cells reported on liquid-based cervical cytology A Patel, a N Thampy, b D Hemming, b

More information

cle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil BJMP 2008:1(2) 18-22

cle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil BJMP 2008:1(2) 18-22 BJMP 2008:1(2) 18-22 Review Articl cle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil Abbreviations BSCCP British Society of Colposcopy and Cervical Pathology CIN Cervical intraepithelial

More information

ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust

ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust ZedScan Case Study NHS Hospital, UK. ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust Increased detection

More information

CPC on Cervical Pathology

CPC on Cervical Pathology CPC on Cervical Pathology Dr. W.K. Ng Senior Medical Officer Department of Clinical Pathology Pamela Youde Nethersole Eastern Hospital Cervical Smear: High Grade SIL (CIN III) Cervical Smear: High Grade

More information

How invasive cervical cancer audit affects clinical practice

How invasive cervical cancer audit affects clinical practice How invasive cervical cancer audit affects clinical practice Referring to NHSCSP and EU guidelines and audits in Southampton and London Amanda Herbert Guy s & St Thomas Foundation NHS Trust How invasive

More information

The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial

The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial DOI: 10.1111/j.1471-0528.2010.02519.x www.bjog.org Epidemiology The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial

More information

Northern Ireland cervical screening programme. Information for primary care and smear takers

Northern Ireland cervical screening programme. Information for primary care and smear takers Northern Ireland cervical screening programme Information for primary care and smear takers From January 2011, the Northern Ireland cervical screening programme will no longer invite women aged under 25

More information

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates

More information

The treatment of CIN: what are the risks?

The treatment of CIN: what are the risks? REVIEW ARTICLE DOI:10.1111/j.1365-2303.2009.00669.x The treatment of CIN: what are the risks? Royal College of Surgeons in Ireland, Department of Gynaecology, Coombe and Tallagh Hospital, Dublin, Ireland

More information

Human papillomavirus type 16 and 18 detection in the management of mild dyskaryosis

Human papillomavirus type 16 and 18 detection in the management of mild dyskaryosis British Journal of Obstetrics and Gynaecology September 1999, Vol106, pp. 969-976 Human papillomavirus type 16 and 18 detection in the management of mild dyskaryosis *Margaret E. Cruickshank Clinical Research

More information

ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust

ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust ZedScan Case Study NHS Hospital, UK. ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust Increased detection

More information

Management that provides continuity of care for women

Management that provides continuity of care for women Management that provides continuity of care for women If women are diagnosed with reproductive tract infection, prompt treatment should be instituted according to the WHO guidelines. Though it may be preferred

More information

Glandular Atypia In Cervical Smear: Cytohistologic And Clinical Correlation. K Elsapagh, S Swain, S Ghosh, H Dunsmore, K McMullen, J Steven, K Morton

Glandular Atypia In Cervical Smear: Cytohistologic And Clinical Correlation. K Elsapagh, S Swain, S Ghosh, H Dunsmore, K McMullen, J Steven, K Morton ISPUB.COM The Internet Journal of Gynecology and Obstetrics Volume 5 Number 2 Glandular Atypia In Cervical Smear: Cytohistologic And Clinical Correlation K Elsapagh, S Swain, S Ghosh, H Dunsmore, K McMullen,

More information

Colposcopic Proficiency-Disease Spectrum in a Single Family Practice Colposcopists Clinic

Colposcopic Proficiency-Disease Spectrum in a Single Family Practice Colposcopists Clinic Colposcopic Proficiency-Disease Spectrum in a Single Family Practice Colposcopists Clinic Gregory L. Brotzman, MD; Kenneth G. Schellhase, MD, MPH ABSTRACT Purpose: We sought to assess colposcopic proficiency

More information

Keywords Cytology-screening, statistics-epidemiological surveys.

Keywords Cytology-screening, statistics-epidemiological surveys. DOI: 10.1111/j.1471-0528.2007.01467.x www.blackwellpublishing.com/bjog Epidemiology An examination of the role of opportunistic smear taking in the NHS cervical screening programme using data from the

More information

Cytology Update M Laing QEUH

Cytology Update M Laing QEUH Cytology Update M Laing QEUH Age change to 25 to 65 Age 25 to 50 Three yearly smear invitation Age 50 to 65 Five yearly smear invitation Women on non routine screening will be invited up to age 70 OUTCOME

More information

Cervical Cancer Screening. David Quinlan December 2013

Cervical Cancer Screening. David Quinlan December 2013 Cervical Cancer Screening David Quinlan December 2013 Cervix Cervical Cancer Screening Modest variation provincially WHO and UK begin at 25 stop at 60 Finland begin at 30 stop at 60 Rationale for

More information

High-grade vaginal intraepithelial neoplasia: can we be selective about who we treat?

High-grade vaginal intraepithelial neoplasia: can we be selective about who we treat? DOI: 10.1111/1471-0528.12223 www.bjog.org Gynaecological oncology High-grade vaginal intraepithelial neoplasia: can we be selective about who we treat? N Ratnavelu, a A Patel, a AD Fisher, a K Galaal,

More information

This paper includes Author Insights, a video abstract available at

This paper includes Author Insights, a video abstract available at DOI: 10.1111/1471-0528.14808 www.bjog.org Epidemiology Risk of persistent or recurrent cervical neoplasia in patients with pure adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous

More information

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Glossary of Terms Colposcopy is the examination of the cervix, vagina and, in

More information

The implications of HPV immunisation on cervical screening

The implications of HPV immunisation on cervical screening The implications of HPV immunisation on cervical screening Dr Maggie Cruickshank Senior Lecturer in Gynaecology Scottish Cervical Cancer Prevention Programme (SCCPP) funded by CSO Cervical screening Detects

More information

EFC and European Standards for Colposcopic Evaluation

EFC and European Standards for Colposcopic Evaluation EFC and European Standards for Colposcopic Evaluation Cagatay Taskiran, MD. Koc University School of Medicine, and VKF American Hospital Department of Obstetrics and Gynecology Division of Gynecologic

More information

WIRRAL UNIVERSITY TEACHING HOSPITAL CYTOLOGY NHS CERVICAL SCREENING PROGRAMME INFORMATION PACK FOR SAMPLE TAKERS

WIRRAL UNIVERSITY TEACHING HOSPITAL CYTOLOGY NHS CERVICAL SCREENING PROGRAMME INFORMATION PACK FOR SAMPLE TAKERS Author J. Evans BMS 3 Authoriser A. Bamber Page 1 of 16 WIRRAL UNIVERSITY TEACHING HOSPITAL CYTOLOGY NHS CERVICAL SCREENING PROGRAMME INFORMATION PACK FOR SAMPLE TAKERS Author J. Evans BMS 3 Authoriser

More information

Plus ça change. CWE Redman Colposcopy Symposium, ECC 2016

Plus ça change. CWE Redman Colposcopy Symposium, ECC 2016 Plus ça change. CWE Redman Colposcopy Symposium, ECC 2016 UHNM What we know HPV primary screening coming More sensitive: more HSIL detected Increase in workload Longer consultations More anxiety HPV Primary

More information

The comparative diagnostic accuracy of conventional and liquid-based cytology in a colposcopic setting

The comparative diagnostic accuracy of conventional and liquid-based cytology in a colposcopic setting BJOG: an International Journal of Obstetrics and Gynaecology November 2005, Vol. 112, pp. 1542 1546 DOI: 10.1111/j.1471-0528.2005.00699.x The comparative diagnostic accuracy of conventional and liquid-based

More information

NHSCSP proposals for cervical screening intervals. Comments and recommendations of Council of the British Society for Clinical Cytology

NHSCSP proposals for cervical screening intervals. Comments and recommendations of Council of the British Society for Clinical Cytology NHSCSP proposals for cervical screening intervals Comments and recommendations of Council of the British Society for Clinical Cytology The following paper is written on behalf of BSCC Council to express

More information

A clinical review of borderline glandular cells on cervical cytology

A clinical review of borderline glandular cells on cervical cytology British Journal of Obstetrics and Gynaecology May 2000, Vol07, pp. 605-609 A clinical review of borderline glandular cells on cervical cytology D. Kusnah A. Mohammed Research Senior House Oflcer, Ofer

More information

Outcomes for women without conventional treatment for stage 1A (microinvasive) carcinoma of the cervix

Outcomes for women without conventional treatment for stage 1A (microinvasive) carcinoma of the cervix Aust N Z J Obstet Gynaecol 2018; 58: 321 329 DOI: 10.1111/ajo.12753 ORIGINAL ARTICLE Outcomes for women without conventional treatment for stage 1A (microinvasive) carcinoma of the cervix Charlotte Paul

More information

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) The cervix constitutes the lower third of the uterus. It is in two parts, the endocervix and the ectocervix. Ectocervix is covered with squamous epithelium. Endocervix

More information

Article ID: WMC

Article ID: WMC Article ID: WMC001971 2046-1690 Evaluation of Visual Inspection with Acetic Acid (Via) & Visual Inspection with Lugol's Iodine (Vili) as a Screening Tool for Cervical Intraepithelial Neoplasia in Comparison

More information

Guideline for the Follow-up of Patients with Gynaecological Malignancies

Guideline for the Follow-up of Patients with Gynaecological Malignancies Guideline for the Follow-up of Patients with Gynaecological Malignancies Version History Version Date Summary of Change/Process 2.0 20.02.08 Endorsed by the Governance Committee 2.1 18.11.10 Circulated

More information

POST-CONIZATION FOLLOW-UP OF PATIENTS WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION TREATED BY LEEP PROCEDURE: A LITERATURE REVIEW

POST-CONIZATION FOLLOW-UP OF PATIENTS WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION TREATED BY LEEP PROCEDURE: A LITERATURE REVIEW POST-CONIZATION FOLLOW-UP OF PATIENTS WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION TREATED BY LEEP PROCEDURE: A LITERATURE REVIEW Boureima Ali Nafissatou and Dong zhao * Department of Gynecology, Shanghai

More information

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health

More information

Gynaecological Pathology Reporting Cervical Pathology Dr Raji Ganesan Birmingham

Gynaecological Pathology Reporting Cervical Pathology Dr Raji Ganesan Birmingham Gynaecological Pathology Reporting Cervical Pathology Dr Raji Ganesan Birmingham Format Introduction Cervical biopsy Difficulties in diagnosis of CIN p16 Cervical loop Squamous carcinoma diagnosing and

More information

POLICY FOR CLINICAL AUDIT OF NEW CASES OF INVASIVE CERVICAL CANCER AND DISCLOSURE OF RESULTS

POLICY FOR CLINICAL AUDIT OF NEW CASES OF INVASIVE CERVICAL CANCER AND DISCLOSURE OF RESULTS POLICY FOR CLINICAL AUDIT OF NEW CASES OF INVASIVE CERVICAL CANCER AND DISCLOSURE OF RESULTS Reference Number Version: Status Author: Alison Cropper CL-CP/2009/010 V3 Final Job Title: Hospital Based Programme

More information

Management Algorithms for Abnormal Cervical Cytology and Colposcopy

Management Algorithms for Abnormal Cervical Cytology and Colposcopy Management Algorithms for Abnormal Cervical Cytology and Colposcopy Table of Contents Standard Colposcopic Definitions... 1 Guidelines for the Assessment of Abnormal Cervical Cytology... 2 Ia: Persistent

More information

CERVICAL SCREENING WALES CERVICAL SCREENING PROGRAMME, WALES: 2001/02

CERVICAL SCREENING WALES CERVICAL SCREENING PROGRAMME, WALES: 2001/02 CERVICAL SCREENING WALES INFORMATION TEAM STATISTICAL REPORT CERVICAL SCREENING PROGRAMME, WALES: 2001/02 For more information about this report contact: Helen Beer, Information Analyst / Manager, Screening

More information

GUIDELINES FOR CERVICAL CYTOLOGY SPECIMENS CA1066 (V8) Approved by Guidelines Assessment Panel

GUIDELINES FOR CERVICAL CYTOLOGY SPECIMENS CA1066 (V8) Approved by Guidelines Assessment Panel NORFOLK & WAVENEY CELLULAR PATHOLOGY SERVICE GUIDELINES FOR CERVICAL CYTOLOGY SPECIMENS CA1066 (V8) DEPT. SOP NO.:C.SC.I.806b EDITION: 8 AUTHORISED BY: See table below AUTHOR: VIKI FREW DATE OF ISSUE:

More information

ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests

ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests www.treatmentok.com Barbara S. Apgar, MD, MS Professor of Family Medicine University of Michigan Ann Arbor, Michigan Disclosures

More information

To further assess abnormalities detected on cervical cytological sample. To guide colposcopically directed biopsy

To further assess abnormalities detected on cervical cytological sample. To guide colposcopically directed biopsy 1 To further assess abnormalities detected on cervical cytological sample To guide colposcopically directed biopsy To exclude invasive disease To aid in outpatient management and treatment of precancerous

More information

Cervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital

Cervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital Cervical Skills Dr Margaret Laing Queen Elizabeth University Hospital What is screening? Screening is a test offered to an apparently well person with the possibility of detecting a serious disease before

More information

!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$

!#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ !"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology

More information

Chapter 10: Pap Test Results

Chapter 10: Pap Test Results Chapter 10: Pap Test Results On completion of this section, the learner will be able to: 1. Identify how Pap test results are interpreted and the reasons for normal and abnormal results. 2. Describe the

More information

Original Article Three-step approach versus see-and-treat approach in patients with cytological abnormalities

Original Article Three-step approach versus see-and-treat approach in patients with cytological abnormalities Int J Clin Exp Med 2013;6(5):372-376 www.ijcem.com /ISSN:1940-5901/IJCEM1304013 Original Article Three-step approach versus see-and-treat approach in patients with cytological abnormalities Nilgun Guducu

More information

,,,,, PATHOLOGY QUIZ PATHOLOGY Q U I Z

,,,,, PATHOLOGY QUIZ PATHOLOGY Q U I Z ,,,,, PATHOLOGY Q U I Z,,,,, PATHOLOGY QUIZ CASE HISTORY Alex Ferenczy, MD, Professor of Pathology and Obstetries and Gynaecology, The Sir Mortimer B. Davis ]ewish General HosPital, McGill University This

More information

Cervical Dysplasia and HPV

Cervical Dysplasia and HPV Cervical Dysplasia and HPV J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse HPV Double stranded DNA virus The HPV infect epithelial cells of the skin and mucous membranes Highest risk

More information

Department of Pathology, Kathmandu Medical College & Teaching Hospital, Sinamangal, Kathmandu, Nepal

Department of Pathology, Kathmandu Medical College & Teaching Hospital, Sinamangal, Kathmandu, Nepal Kathmandu University Medical Journal (2007), Vol. 5, No. 4, Issue 20, 461-467 Original Article Correlation of PAP smear findings with clinical findings and cervical biopsy Pradhan B 1, Pradhan SB 2, Mital

More information

The Management of Minor Degrees of Cervical Dysplasia Associated with the Human Papilloma Virus

The Management of Minor Degrees of Cervical Dysplasia Associated with the Human Papilloma Virus THE YALE JOURNAL OF BIOLOGY AND MEDICINE 64 (1991), 591-597 The Management of Minor Degrees of Cervical Dysplasia Associated with the Human Papilloma Virus JOHN A. CARMICHAEL, M.D., C.M., F.R.C.S.C. Division

More information

Managament of Abnormal Cervical Cytology and Histology

Managament of Abnormal Cervical Cytology and Histology Managament of Abnormal Cervical Cytology and Histology Ali Ayhan, M.D Başkent University Faculty of Medicine Department of Gynecology and Obstetrics Division of Gynecologic Oncology Abnormal Cytologic

More information

Cervical Conization. 1

Cervical Conization.   1 Cervical Conization www.zohrehyousefi.com 1 Cone Biopsy is a surgical procedure with removal of a cone shaped portion of the cervix The extent of involvement of epithelium on the ectocervix has been clearly

More information

6 th EFC Satellite meeting, Saturday 1 st December 2018

6 th EFC Satellite meeting, Saturday 1 st December 2018 6 th EFC Satellite meeting, Saturday 1 st December 2018 Introduction Pekka Nieminen President-elect of the European Federation for Colposcopy, Department of Obstetrics and Gynaecology, Helsinki University

More information

Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test(review)

Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test(review) Cochrane Database of Systematic Reviews Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test Kyrgiou M, Kalliala IEJ,

More information

Cervical surgery for cervical intraepithelial neoplasia and prolonged time to conception of a live birth: a case control study

Cervical surgery for cervical intraepithelial neoplasia and prolonged time to conception of a live birth: a case control study DOI: 10.1111/1471-0528.12209 www.bjog.org Epidemiology Cervical surgery for cervical intraepithelial neoplasia and prolonged time to conception of a live birth: a case control study CN Spracklen, a KK

More information

Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy

Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy ACTA BIOMED 2007; 78: 36-40 Mattioli 1885 O R I G I N A L A R T I C L E Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy

More information

Cuid d Fheidhmeannacht na Seirbhíse Sláinte. Part of the Health Service Executive. CS/PR/PM-20 Rev 2 ISBN Programme Report 2014/2015

Cuid d Fheidhmeannacht na Seirbhíse Sláinte. Part of the Health Service Executive. CS/PR/PM-20 Rev 2 ISBN Programme Report 2014/2015 Programme Report 2014/2015 Contents Summary points 2 Introduction to the statistics 2014/2015 3 Part 1 Cervical screening activity 3 Programme coverage 4 Laboratory turnaround time 7 Notification of results

More information

Colposcopy. Attila L Major, MD, PhD

Colposcopy. Attila L Major, MD, PhD Colposcopy Attila L Major, MD, PhD Histology Colposcopy Cytology It has been estimated that annual Pap smear testing reduces a woman s chance of dying of cervical cancer from 4 in 1000 to about 5 in 10,000

More information

The society for lower genital tract disorders since 1964.

The society for lower genital tract disorders since 1964. The society for lower genital tract disorders since 1964. Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology

More information

Name of External Assessment Group (EAG) and project leads

Name of External Assessment Group (EAG) and project leads Title of the project Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: a systematic review and economic evaluation Name of External Assessment Group (EAG) and project leads

More information

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Fadi W. Abdul-Karim MD MEd. Professor of Pathology. Vice chair for education. Robert Tomsich Pathology and Lab Med

More information

An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme Sherlaw-Johnson C, Philips Z

An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme Sherlaw-Johnson C, Philips Z An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme Sherlaw-Johnson C, Philips Z Record Status This is a critical abstract of an economic

More information

KC53/61/65 Statistical Report Adroddiad Ystadegol 2012/13 Prepared by Cervical Screening Wales

KC53/61/65 Statistical Report Adroddiad Ystadegol 2012/13 Prepared by Cervical Screening Wales KC53/61/65 Statistical Report Adroddiad Ystadegol 2012/13 Prepared by Cervical Screening Wales CERVICAL SCREENING WALES STATISTICAL REPORT CERVICAL SCREENING PROGRAMME, WALES: 2012/2013 For more information

More information

I have no financial interests to disclose.

I have no financial interests to disclose. Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics I have no financial interests

More information

Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D.

Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D. Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D. 27 May, 2014 London, England Faculty Disclosure X No, nothing to disclose Yes, please specify

More information

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14 LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 09/5/95 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.

More information

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists HKCOG Guidelines Guidelines on the Management of An Abnormal Cervical Smear Number 3 revised November 2002 published by The Hong Kong College of Obstetricians and Gynaecologists A Foundation College of

More information

Partha Basu M.D. Screening Group/ Early Detection & Prevention Section

Partha Basu M.D. Screening Group/ Early Detection & Prevention Section Current Status of Quality Assured Colposcopy Practice in South Asia Partha Basu M.D. Screening Group/ Early Detection & Prevention Section Disclosures No financial disclosure NO conflict of interest to

More information

Over-diagnoses in Cytopathology: Is histology the gold standard?

Over-diagnoses in Cytopathology: Is histology the gold standard? Over-diagnoses in Cytopathology: Is histology the gold standard? Teresa M. Darragh, MD UCSF Departments of Pathology and Obstetrics, Gynecology & Reproductive Sciences Faculty Disclosures: Teresa M. Darragh,

More information

Making Sense of Cervical Cancer Screening

Making Sense of Cervical Cancer Screening Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because

More information

EU guidelines for reporting gynaecological cytology

EU guidelines for reporting gynaecological cytology EU guidelines for reporting gynaecological cytology Amanda Herbert Guy s & St Thomas Foundation NHS Trust 5th EFCS Annual Tutorial, Trondheim, Norway 28 th May 1 st June 2012 EU guidelines aim to harmonize

More information

GYNAECOLOGICAL CYTOLOGY

GYNAECOLOGICAL CYTOLOGY The laboratory runs a tour of the department for Practice Nurses on request, as part of their training, explaining the procedures and requirements for Gynae LBC. RECOMMENDED PROTOCOL FOR SMEAR TAKERS Only

More information

Chapter 8 Adenocarcinoma

Chapter 8 Adenocarcinoma Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted

More information

I have no financial interests in any product I will discuss today.

I have no financial interests in any product I will discuss today. Cervical Cancer Screening Update and Implications for Annual Exams George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics

More information

pat hways Medtech innovation briefing Published: 12 February 2015 nice.org.uk/guidance/mib20

pat hways Medtech innovation briefing Published: 12 February 2015 nice.org.uk/guidance/mib20 pat hways The ZedScan as an adjunct to colposcopy in women with suspected cervical intra-epithelial neoplasia Medtech innovation briefing Published: 12 February 2015 nice.org.uk/guidance/mib20 Summary

More information

Biomed Environ Sci, 2015; 28(1): 80-84

Biomed Environ Sci, 2015; 28(1): 80-84 80 Biomed Environ Sci, 2015; 28(1): 80-84 Letter to the Editor Assessing the Effectiveness of a Cervical Cancer Screening Program in a Hospital-based Study* YANG Yi1, LANG Jing He1, WANG You Fang1, CHENG

More information

Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY

Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY Evidence-Based Medicine Two-Step Discrepancy 1 Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY Evidence-Based Medicine Two-Step Discrepancy Julie Nelson Texas Woman s University Philosophy of

More information

The value of primary colposcopy in genitourinary

The value of primary colposcopy in genitourinary Genitourin Med 1994;70:191-195 The value of primary colposcopy in genitourinary medicine-a six year review 191 Doncaster Royal Infirmary & Montagu Hospital NHS Trust, Armthrope Road, Doncaster DN2 SLT,

More information

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

GLANDULAR LESIONS PITFALLS IN MANAGEMENT. Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016

GLANDULAR LESIONS PITFALLS IN MANAGEMENT. Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016 GLANDULAR LESIONS PITFALLS IN MANAGEMENT Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016 Introduction Cervical glandular lesions are much less common than squamous lesion Incidence

More information

Cvtobrush and endocervical curettarre in the d$gnosis of dysplasia and rnalignaky of the uterine cervix

Cvtobrush and endocervical curettarre in the d$gnosis of dysplasia and rnalignaky of the uterine cervix ACIU Ohstrt Gj~17ewl Scuizrl 1997: 76: 69-73 Printed in Dmmurk - ull rights reserwd Cojniiqhf 0 4cto 0hrie.r Gi,ir~olScu,id1997 Acta Obstetricia et Gynecologica Scandinavica ISShi 0001-6349 ORIGINAL ARTICLE

More information

Colposcopic Evaluation Of Patients With Abnormal Cervical Cytology And Its Histopathological Corelation An Original Article

Colposcopic Evaluation Of Patients With Abnormal Cervical Cytology And Its Histopathological Corelation An Original Article ISPUB.COM The Internet Journal of Gynecology and Obstetrics Volume 18 Number 1 Colposcopic Evaluation Of Patients With Abnormal Cervical Cytology And Its Histopathological Corelation An Original Article

More information

Fluorescence Spectroscopy: A New Approach in Cervical Cancer

Fluorescence Spectroscopy: A New Approach in Cervical Cancer DOI 10.1007/s13224-012-0298-6 ORIGINAL ARTICLE : A New Approach in Cervical Cancer Pandey Kiran Pradhan Asima Agarwal Asha Bhagoliwal Ajay Agarwal Nidhi Received: 2 June 2008 / Accepted: 7 August 2012

More information

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14 LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 08/5/94 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.

More information